NYSE:ABBVBiotechs
AbbVie’s US$1.4b AI-Powered Campus Reshapes Immunology And Neuroscience Story
AbbVie (NYSE:ABBV) is committing $1.4b to a new pharmaceutical manufacturing campus in North Carolina.
The facility will use advanced technologies and AI to support global production of immunology, neuroscience, and oncology medicines.
The project is expected to create hundreds of skilled jobs and marks AbbVie’s largest single facility investment to date.
For investors following large-cap pharma, this move highlights how AbbVie is expanding its manufacturing footprint in the U.S. The...